SPHRY OTC
Starpharma Holdings Limited
1W: -12.2%
1M: -4.7%
3M: +9.8%
YTD: +94.2%
1Y: +197.1%
3Y: +127.5%
5Y: -51.0%
$5.05
-0.80 (-13.68%)
Weekly Expected Move ±13.3%
$4
$4
$5
$6
$6
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$12M
+101.5% ▲
5Y CAGR: +27.6%
Gross Profit
$10M
+372.6% ▲
5Y CAGR: +79.9%
Operating Income
-$19M
+14.8% ▲
Net Income
-$7M
+26.9% ▲
EPS (Diluted)
$-0.17
+27.6% ▲
EBITDA
-$19M
-93.5% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $5M | $4M | $8M | $6M | $12M |
| YoY Growth | +48.0% | -15.9% | +90.9% | -29.4% | +101.5% |
| Cost of Revenue | $3M | $2M | $632K | $10M | $2M |
| Gross Profit | $2M | $1M | $8M | -$4M | $10M |
| Gross Margin | 36.9% | 28.1% | 92.4% | -63.7% | 86.3% |
| R&D Expenses | $19M | $19M | $16M | $12M | $0 |
| SG&A Expenses | $7M | $8M | $7M | $6M | $7M |
| Operating Expenses | $26M | $26M | $18M | $18M | $29M |
| Operating Income | -$35M | -$35M | -$11M | -$22M | -$19M |
| Operating Margin | -679.9% | -794.6% | -129.7% | -377.3% | -159.6% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$16M | -$16M | -$8M | -$10M | -$18M |
| Tax Expense | $0 | $0 | $0 | $0 | -$11M |
| Net Income | -$16M | -$16M | -$8M | -$10M | -$7M |
| Net Margin | -312.9% | -360.1% | -98.5% | -170.8% | -62.0% |
| EPS (Diluted) | $-0.40 | $-0.38 | $-0.20 | $-0.24 | $-0.17 |
| EBITDA | -$16M | -$17M | -$10M | -$10M | -$19M |
| Shares Outstanding | 41M | 41M | 41M | 42M | 43M |